Feasibility of a single-visit approach using rapid HPV-testing in Cameroo

Not Applicable

Completed

• Conditions: Cervical cancer; Cancer

• Registration Number: ISRCTN99459678
• Lead Sponsor: Geneva University Hospitals (Hôpitaux Universitaires de Genève)

Brief Summary

2017 Results article in https://www.ncbi.nlm.nih.gov/pubmed/28580596 results 2017 Other publications in https://pubmed.ncbi.nlm.nih.gov/28061842/ (added 30/12/2022)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-11-01
• Study Completion: 2016-08-31
• Last Update Posted: 9 January 2023

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 1000

Inclusion Criteria

1. Women aged 30-49
2. Understanding of study procedures

Exclusion Criteria

1. Pregnancy
2. Previous hysterectomy
3. Conditions that can interfere with visualization of the cervix (menstruation)
4. Women who not able to comply with protocol study

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> Current primary outcome measures as of 26/09/2017:<br> The feasibility of HPV cervical cancer screen-and-treat approach in a low-resource context, assessed by measuring the number of women who took part in the screening campaign and the relative number of drop-outs and invalid test results at baseline<br><br> Previous primary outcome measures:<br> The prevalence of HPV infection and cervical pre-cancer and cancer will be determined among Cameroonian women at baseline, 6 months and 1 year<br>